Travere Therapeutics (TVTX) Current Deferred Revenue (2021 - 2024)
Travere Therapeutics (TVTX) posted Current Deferred Revenue of $2.82 million for Q4 2024, down 60.3% from $7.1 million a year earlier and down 25.9% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Current Deferred Revenue (2021 - 2024) Analysis & Trends
Since Q3 2021, Travere Therapeutics has reported Current Deferred Revenue for 14 quarters.
- Annual Current Deferred Revenue has declined for three consecutive years, with a three-year compound annual growth rate of -44.3% (FY2021 to FY2024).
- In prior years, Travere Therapeutics' Current Deferred Revenue was $7.1 million in FY2023 (-40.7%), $11.98 million in FY2022 (-26.4%) and $16.27 million in FY2021.
- The Q4 2024 figure stands as the lowest quarterly Current Deferred Revenue in data going back to Q3 2021.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last ten quarters, with an average decline of 38.7% over the last eight quarters.
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 18.1% (Q2 2023) to 60.3% (Q4 2024).
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $3.8 million (Q3 2024), $5.38 million (Q2 2024) and $6.46 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Travere Therapeutics | 4.88 Bn | 4.48 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 2.82 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 5.38 Mn |
| Mar 31, 2024 | 6.46 Mn |
| Dec 31, 2023 | 7.10 Mn |
| Sep 30, 2023 | 8.96 Mn |
| Jun 30, 2023 | 10.24 Mn |
| Mar 31, 2023 | 10.98 Mn |
| Dec 31, 2022 | 11.98 Mn |
| Sep 30, 2022 | 11.38 Mn |
| Jun 30, 2022 | 12.50 Mn |
| Mar 31, 2022 | 14.23 Mn |
| Dec 31, 2021 | 16.27 Mn |
| Sep 30, 2021 | 16.07 Mn |
API Access
Travere Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();